04/22/2021 | Press release | Distributed by Public on 04/22/2021 04:59

VOLUNTARY ANNOUNCEMENT - TORIPALIMAB PLUS CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADVANCED OR METASTATIC ESOPHAGEAL CANCER REACHED PRIMARY ENDPOINTS IN A PHASE III CLINICAL STUDY

Please select the service you want to use:

• Newsvine
• Digg
• Delicious
• StumbleUpon
• Technorati
• Buzz
• Favorites
• Google Reader

 Back

 Download the original document